Filing Details

Accession Number:
0001140361-10-036762
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-09 19:18:03
Reporting Period:
2010-09-08
Filing Date:
2010-09-09
Accepted Time:
2010-09-09 19:18:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-08 35,000 $11.74 72,587 No 4 M Direct
Common Stock Disposition 2010-09-08 35,000 $22.00 37,587 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-09-08 35,000 $0.00 35,000 $11.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
435,000 2006-07-06 2016-01-05 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 105-1 Trading plan executed on March 10, 2010.
  2. Original option vests 12/36ths on July 1, 2006 and 1/36th on the 1st of every month thereafter.